HOME >> BIOLOGY >> NEWS
Vanderbilt doctors use Viagra to treat infants with pulmonary hyptertension

Doctors at Vanderbilt Children's Hospital have found a whole new use for the popular erectile dysfunction drug Viagra.

Sildenafil, as it is called by its more anonymous chemical name, may have the power to save babies. Chronic pulmonary hypertension is virtually a death sentence in newborn babies. It can begin with a heart defect, or for reasons that are not well explained; but when the blood pressure rises inside the lungs and stays that way, there is often little that can be done.

But a few small studies have recently suggested that babies with deadly pulmonary hypertension may respond with good success to Sildenafil.

In the case of 6-month-old Hartley Wilson, Don Moore, M.D., a pediatric cardiologist at Vanderbilt Children's Hospital, had to make a difficult decision. Shortly after birth, Hartley had emergency surgery to correct a heart defect known as total anomalous pulmonary venous return. He remained in the hospital for the next two months.

"After a brief stay at home, he was readmitted to the hospital," Moore said. "The blood pressure in his lungs was five or six times normal and the right side of his heart was struggling to function," recalled Moore.

Time was ticking away from the moment then-3-month-old Hartley returned to Vanderbilt Children's Hospital. Very high pressures, like his can cause heart failure and death. Hartley was rushed to cardiac catheterization in order to get an accurate reading of the pressure in his lungs.

Even after a successful heart surgery, like Hartley's, problems may develop that result in pulmonary hypertension. It could be vessels that are prone to clotting or scarring after surgery, or vessels throughout the lungs that have a tendency to tighten, reducing the freedom of blood flow from the lungs back to the heart.

During the procedure, Moore tried a drug well known to reduce deadly pulmonary hypertension in infants: an inhaled drug called nitric oxide.

"It dilates, or relaxes
'"/>

Contact: Carole Bartoo
carole.bartoo@vanderbilt.edu
615-322-4747
Vanderbilt University Medical Center
19-Apr-2004


Page: 1 2 3

Related biology news :

1. Vanderbilt students take HHMI fellowships
2. Vanderbilts John Oates wins clinical research award
3. Vanderbilt doctors find citrus soda interacts with cyclosporine, maybe statins
4. Vanderbilt researchers receive fellowships to support early identification, genetic causes of autism
5. Vanderbilt, Meharry establish new Center for AIDS Research
6. Researchers at Vanderbilts Free-Electron Laser Center are developing new forms of laser surgery, improved X-ray technology, and better methods for protein identification
7. National Cancer Institute designates Vanderbilt-Ingram a Comprehensive Cancer Center
8. Vanderbilt neuroscientists identify oops center in the brain
9. Procter & Gamble donates proprietary "super aspirin" technology to Vanderbilt University
10. Vanderbilt archaeological team unearths buried Maya royal palace
11. Matrisian named Vanderbilts first chair of cancer biology

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/18/2020)... ... ... Commercial launch readiness is a critical stage in a product life cycle. While the ... economic downturn will only increase price pressures overall for the industry. The era of ... every product launch is critical. However, history shows that only a third of product ...
(Date:7/10/2020)... ... ... Today CJ BIO announced the first in a series of Food Ingredient ... that is revolutionizing ingredient mixes, nutritional content and flavor profiles across a range of ... 2020 at11:00 AM (CDT) during SHIFT20, the virtual edition of the IFT Annual Meeting ...
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio ... findings of Neihulizumab, a biologic for the treatment of steroid-refractory acute graft-versus-host disease ... hemato-oncologist Dr. Paul J Martin of the Fred Hutchinson Cancer Research Center, this ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... ... August 11, 2020 , ... Modality ... for free its new white paper – Simulated Transport Methodologies. Regulatory expectations ... biologics licensing application (BLA). In response, Modality Solutions shares an explanation of ...
(Date:8/3/2020)... LEXINGTON, Ky. (PRWEB) , ... August 03, 2020 , ... ... innovative products for transformative growth, , Known as MediVet Biologics ... Health brand. , The new Ardent Animal Health will build on its ...
(Date:7/31/2020)... , ... July 29, 2020 , ... ... can combine up to three different materials for use with CRM, neurostimulation, vascular, ... to three materials to meet specific design requirements, performance, and cost criteria; especially ...
(Date:7/31/2020)... ... July 30, 2020 , ... Alucio™, ... announced the release of its signature product called Beacon - a content ... other field medical professionals. , Beacon helps MSLs streamline communication and ...
Breaking Biology Technology:
Cached News: